Cell (1)
Launched (1)
Human (1)
- (1)
- (1)
| Cat. No. | Species | Host | Product Description | Structure | Purity | Feature | Order Now |
|---|---|---|---|---|---|---|---|
CHEK-ATP205 | HEK293 | HEK293/Human GLP-1R&GIPR Stable Cell Line |
| English Name | Research Code | Highest Development Stage | Company | Indication | Clinical Trial |
|---|---|---|---|---|---|
| Dyne-101 | Dyne101 | Phase 2 Clinical | Myotonic Dystrophy; Muscular Atrophy | Details | |
| ARO-DM1 | ARO-DM1 | Phase 2 Clinical | Arrowhead Pharmaceuticals Inc | Myotonic Dystrophy | Details |

[North America]: +1 800-810-0816
[Switzerland]: +41 800 040 012
[Asia & Pacific]: +86 400-682-2521
[North America]: 1 Innovation Way, Newark, DE 19711, USA
[Switzerland]: ACRObiosystems AG, c/o Zug Dammstrasse Centre AG, Dammstrasse 19, 6300 Zug Switzerland



